Tag Archives: IBKR

Hot Bank Stocks To Invest In 2019

The last few years have been absolutely brutal for Ensco (NYSE:ESV) and every other offshore oil rig company. As oil prices started to crash back in 2014, companies stopped renting rigs for exploration and development in order to conserve cash. To make matters worse, rig companies had spent billions on expanding their fleets in the years before this.

It left all of them with too many rigs, not enough customers, and uncomfortably large debt levels that led to sinking stock prices and a couple of high-profile bankruptcies.

Now that oil prices are on the mend and oil producers are starting to open their wallets again, some investors might be wondering if it is time to take another look at Ensco. After all, the company’s stock trades for a dirt cheap price-to-tangible-book-value of 0.32. So let’s go through Ensco’s numbers and gauge the way the wind is blowing for the offshore industry to get a handle on whether this stock is a buy or not.

Hot Bank Stocks To Invest In 2019: Veeva Systems Inc.(VEEV)

Advisors’ Opinion:

  • [By Keith Speights]

    It provides cloud-based software to healthcare companies. And it has a track record of strong revenue and earnings growth. Which company is it? Veeva Systems (NYSE:VEEV) is a correct answer. So is athenahealth (NASDAQ:ATHN).  

  • [By Keith Speights]

    Veeva Systems Inc. (NYSE:VEEV) stock isn’t too far away from doubling in 2018, with over three months remaining in the year. Shares of the life sciences cloud solutions provider are at all-time highs with no end in sight to its momentum.

  • [By Motley Fool Staff]

    Matt Wallach is the co-founder and president of Veeva Systems (NYSE:VEEV), a cloud-based software company that found success catering to the life-sciences industry. But the company isn’t stopping there.

Hot Bank Stocks To Invest In 2019: JAKKS Pacific, Inc.(JAKK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on JAKKS Pacific (JAKK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    JAKKS Pacific, Inc. (NASDAQ:JAKK) – Equities research analysts at Jefferies Financial Group raised their Q2 2018 EPS estimates for JAKKS Pacific in a report issued on Monday, June 18th. Jefferies Financial Group analyst S. Wissink now expects that the company will earn ($0.50) per share for the quarter, up from their prior forecast of ($0.63). Jefferies Financial Group also issued estimates for JAKKS Pacific’s Q4 2018 earnings at ($0.31) EPS, FY2018 earnings at ($0.56) EPS, Q3 2019 earnings at $0.50 EPS and FY2019 earnings at $0.05 EPS.

  • [By Joseph Griffin]

    ValuEngine upgraded shares of Jakks Pacific (NASDAQ:JAKK) from a sell rating to a hold rating in a research report released on Saturday.

    Several other brokerages have also recently weighed in on JAKK. Stifel Nicolaus lowered their target price on Jakks Pacific from $2.70 to $2.50 and set a hold rating on the stock in a report on Friday, April 27th. Zacks Investment Research cut Jakks Pacific from a hold rating to a sell rating in a report on Monday, April 30th. Finally, BMO Capital Markets restated a market perform rating and set a $2.50 target price (down from $3.50) on shares of Jakks Pacific in a report on Friday, February 23rd. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. Jakks Pacific has a consensus rating of Hold and a consensus target price of $2.69.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on JAKKS Pacific (JAKK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By WWW.GURUFOCUS.COM]

    For the details of AXAR CAPITAL MANAGEMENT L.P.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=AXAR+CAPITAL+MANAGEMENT+L.P.

    These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.iShares Russell 2000 (IWM) – 1,060,000 shares, 73.71% of the total portfolio. Stonemor Partners LP (STON) – 6,650,613 shares, 17.03% of the total portfolio. Patterson-UTI Energy Inc (PTEN) – 730,000 shares, 5.58% of the total portfolio. Stage Stores Inc (SSI) – 2,115,200 shares, 2.16% of the total portfolio. Shares added by 20.87%Five Star Senior Living Inc (FVE) – 2,073,398 shares, 1.32% of the total portfolio. Shares added by

  • [By Ethan Ryder]

    JAKKS Pacific, Inc. (NASDAQ:JAKK) was the recipient of a large decline in short interest in the month of August. As of August 15th, there was short interest totalling 1,973,265 shares, a decline of 38.2% from the July 31st total of 3,191,567 shares. Based on an average daily volume of 91,634 shares, the days-to-cover ratio is currently 21.5 days. Approximately 11.4% of the company’s shares are sold short.

Hot Bank Stocks To Invest In 2019: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Billy Duberstein]

    As many investors are aware, last quarter’s stock market was extremely volatile. That should theoretically benefit online brokers, which make money from trading activity. Nevertheless, discount broker Interactive Brokers (NYSEMKT:IBKR) missed expectations for both revenue and earnings per share on its recent earnings release, sending shares down roughly 4% the next day.

  • [By Max Byerly]

    Gamble Jones Investment Counsel increased its stake in shares of Interactive Brokers Group, Inc. (NASDAQ:IBKR) by 1.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,263 shares of the financial services provider’s stock after purchasing an additional 918 shares during the period. Gamble Jones Investment Counsel’s holdings in Interactive Brokers Group were worth $4,139,000 as of its most recent SEC filing.

  • [By Garrett Baldwin]

    Let’s talk the top news in the marijuana industry today… including four stocks that could surge up to 1,000% during this election year. Here’s what you need to know…

    The Top Stock Market Stories for Tuesday
    Goldman Sachs Group Inc. (NYSE: GS) is leading a busy day of earnings reports on Tuesday. Shares are off 0.4% after the firm despite reporting a 40% year-over-year jump in profits and stronger-than-expected revenue. The firm reported earnings per share (EPS) of $5.98 on top of $9.40 billion in revenue. The Wall Street giant was expected to report EPS of $4.67 on top of $8.71 billion in revenue. The investment bank’s first six months of 2018 were its strongest in nine years. The stock slipped after the company announced that president David Solomon will be replacing CEO Lloyd Blankfein when he steps down from his role. Blankfein has been CEO for 12 years. It’s fair to say that Amazon.com Inc. (Nasdaq: AMZN) went to the dogs on Monday. The company has extended its Prime Day promotion through 3 a.m. on Wednesday. The announcement came after the firm suffered significant outages during the start of the event on Monday afternoon. Rather than get access to deals, many customers were met with pictures of dogs, the firm’s standard error page. Finally, pay close attention to events on Capitol Hill on Tuesday. The U.S. House Judiciary Committee will question leaders of Alphabet Inc. (Nasdaq: GOOGL), Twitter Inc. (NYSE: TWTR), and Facebook Inc. (Nasdaq: FB) about how they store and filter user content. Last year, the Senate and House of Representatives slammed the companies for their roles in and responses to Russia’s interference in the 2016 election.
    Three Stocks to Watch Today: CSX, NFLX, KKR
    CSX Corp. (Nasdaq: CSX) will help lead today’s earnings calendar. Wall Street expects that the company will report EPS of $0.86 on top of $2.98 billion in revenue. Shares of Netflix Inc. (Nasdaq: NFLX) slipped after the firm’s user-growth estimates and quart

  • [By Jon C. Ogg]

    Interactive Brokers Group Inc. (NASDAQ: IBKR) has a market cap of almost $26 billion, and its shares were trading basically flat at $62.00, after having been down about 1% in earlier trading indications. The consensus analyst target is $70.50, and the 52-week range is $39.70 to $80.32.

Top 10 Medical Stocks To Own For 2019

Investment company Matthews Pacific Tiger Fund buys Wise Talent Information Technology Co, sells Shandong Weigao Group Medical Polymer Co, AmorePacific Corp, PT Astra International Tbk during the 3-months ended 2018-06-30, according to the most recent filings of the investment company, Matthews Pacific Tiger Fund. As of 2018-06-30, Matthews Pacific Tiger Fund owns 66 stocks with a total value of $9.1 billion. These are the details of the buys and sells.

New Purchases: 06100, Added Positions: 035420, 600887, 524715, 02611, 030000, YUMC, 532155, 139480, SCMA, 005830, Reduced Positions: 01066, 090430, 00700, 01044, 500114, 00291, CPN, BIDU, 3182, VNM, Sold Out: ASII,

For the details of Matthews Pacific Tiger Fund’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Matthews+Pacific+Tiger+Fund

These are the top 5 holdings of Matthews Pacific Tiger FundChina Resources Beer (Holdings) Co Ltd (00291) – 70,257,775 shares, 3.74% of the total portfolio. Shares reduced by 6.77%Kotak Mahindra Bank Ltd (500247) – 16,123,409 shares, 3.48% of the total portfolio. Ping An Insurance (Group) Co. of China Ltd (02318) – 31,734,000 shares, 3.19% of the total portfolio. Baidu Inc (BIDU) – 1,174,300 shares, 3.13% of the total portfolio. Shares reduced by 3.09%Tencent Holdings Ltd (00700) – 5,336,500 shares, 2.94% of the total portfolio. Shares reduced by 9.34%New Purchase: Wise Talent Information Technology Co Ltd (06100)

Matthews Pacific Tiger Fund initiated holding in Wise Talent Information Technology Co Ltd. The purchase prices were between $32.5 and $32.5, with an estimated average price of $32.5. The stock is now traded at around $28.20. The impact to a portfolio due to this purchase was 0.4%. The holding were 8,838,800 shares as of 2018-06-30.

Top 10 Medical Stocks To Own For 2019: BankFinancial Corporation(BFIN)

Advisors’ Opinion:

  • [By Shane Hupp]

    BankFinancial (NASDAQ:BFIN) and Territorial Bancorp (NASDAQ:TBNK) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on BankFinancial (BFIN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on BankFinancial (BFIN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own For 2019: Immersion Corporation(IMMR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ForeScout Technologies (NASDAQ: FSCT) and Immersion (NASDAQ:IMMR) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, profitability and institutional ownership.

  • [By Ethan Ryder]

    Immersion Co. (NASDAQ:IMMR) major shareholder Senvest Management, Llc sold 177,818 shares of the business’s stock in a transaction on Thursday, June 7th. The shares were sold at an average price of $15.93, for a total transaction of $2,832,640.74. The sale was disclosed in a legal filing with the SEC, which is available through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

  • [By Shane Hupp]

    Shares of Immersion Co. (NASDAQ:IMMR) reached a new 52-week high and low during trading on Friday following a stronger than expected earnings report. The stock traded as low as $13.05 and last traded at $12.34, with a volume of 86458 shares trading hands. The stock had previously closed at $13.21.

  • [By Max Byerly]

    Immersion Co. (NASDAQ:IMMR) has been assigned an average rating of “Hold” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $13.13.

  • [By Evan Niu, CFA]

    Shares of Immersion (NASDAQ:IMMR) got crushed today, down by 23% as of 11:50 a.m. EDT, after the developer of haptic technologies reported second-quarter earnings. An unexpected decline in revenue caught investors off guard.

Top 10 Medical Stocks To Own For 2019: SeaWorld Entertainment, Inc.(SEAS)

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    Shares of SeaWorld Entertainment (NYSE:SEAS) have popped today, up by 10% as of 12:20 p.m. EDT, after the company reported first-quarter earnings results. The company enjoyed strong gains in park attendance.

  • [By Daniel B. Kline]

    In this episode of Industry Focus: Consumer Goods, Vincent Shen and Motley Fool contributor Dan Kline take a first pass at understanding what it takes to run a theme park with three of the biggest names in the industry — Six Flags (NYSE:SIX), Cedar Fair (NYSE:FUN), and SeaWorld (NYSE:SEAS).

  • [By Rick Munarriz]

    Investors were ready for SeaWorld Entertainment (NYSE:SEAS) to post its strongest growth in five years on Tuesday morning, and they got a whole lot more. Shares of the marine-life park operator are hitting 11-month highs after the company announced head-turning financial results. 

Top 10 Medical Stocks To Own For 2019: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Jennison Associates LLC raised its position in shares of Bloomin’ Brands Inc (NASDAQ:BLMN) by 15.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 59,634 shares of the restaurant operator’s stock after purchasing an additional 8,083 shares during the quarter. Jennison Associates LLC owned 0.06% of Bloomin’ Brands worth $1,199,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    BidaskClub downgraded shares of Bloomin’ Brands (NASDAQ:BLMN) from a hold rating to a sell rating in a research note issued to investors on Tuesday.

  • [By Max Byerly]

    Wall Street analysts expect Bloomin’ Brands Inc (NASDAQ:BLMN) to post earnings of $0.08 per share for the current quarter, Zacks reports. Five analysts have made estimates for Bloomin’ Brands’ earnings. The highest EPS estimate is $0.12 and the lowest is $0.05. Bloomin’ Brands reported earnings of $0.12 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 33.3%. The firm is expected to report its next earnings results on Friday, November 2nd.

  • [By John Ballard]

    The restaurant industry has had a rough few years. Bloomin’ Brands (NASDAQ:BLMN), owner of Outback Steakhouse, and Brinker International (NYSE:EAT), owner of Chili’s Grill and Bar, were hit particularly hard by traffic trends. Some of this can be attributed to shifts in consumer behavior, as diners more than ever are demanding faster service and quality food preparation. 

  • [By Dan Caplinger]

    Thursday was a volatile day on Wall Street, as major stock indexes lost a lot of ground early in the day but then rebounded to finished mixed. Gains for the Nasdaq Composite came even as Dow Jones Industrial Average fell modestly, and although investors spent much of the session trying to parse through the implications of the latest economic report on retail sales, earnings played a key role in moving many well-known stocks. Marathon Oil (NYSE:MRO), AstraZeneca (NYSE:AZN), and Bloomin’ Brands (NASDAQ:BLMN) were among the top performers. Here’s why they did so well.

  • [By Joseph Griffin]

    Bloomin’ Brands (NASDAQ: BLMN) and Brinker International (NYSE:EAT) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Top 10 Medical Stocks To Own For 2019: MV Oil Trust(MVO)

Advisors’ Opinion:

  • [By Max Byerly]

    MV Oil Trust (NYSE: MVO) and Petroleo Brasileiro SA Petrobras (NYSE:PBR.A) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

  • [By Stephan Byrd]

    Jones Energy (NYSE: MVO) and MV Oil Trust (NYSE:MVO) are both small-cap oils/energy companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, risk and valuation.

Top 10 Medical Stocks To Own For 2019: Acacia Research Corporation(ACTG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Acacia Research (NASDAQ:ACTG) has trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Acacia Research earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.8999050024634 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Logan Wallace]

    These are some of the headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get Acacia Research alerts:

    Insider Selling: Acacia Research Corp (ACTG) President Sells 46,143 Shares of Stock (americanbankingnews.com) Insider Selling: Acacia Research Corp (ACTG) President Sells 66,115 Shares of Stock (americanbankingnews.com) Insider Buying: Acacia Research Corp (ACTG) Insider Acquires 10,000 Shares of Stock (americanbankingnews.com) It may surprise you: OncoSec Medical Incorporated (NASDAQ:ONCS), Mizuho Financial Group, Inc. (NYSE:MFG … (thestreetpoint.com)

    Shares of NASDAQ ACTG traded down $0.05 during midday trading on Tuesday, hitting $3.45. 1,710 shares of the company traded hands, compared to its average volume of 147,059. Acacia Research has a 12-month low of $3.25 and a 12-month high of $5.50. The stock has a market capitalization of $173.23 million, a P/E ratio of 1.16 and a beta of 0.94.

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Top 10 Medical Stocks To Own For 2019: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    UBS Group AG grew its position in Interactive Brokers Group, Inc. (NASDAQ:IBKR) by 20.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,665 shares of the financial services provider’s stock after purchasing an additional 4,558 shares during the quarter. UBS Group AG’s holdings in Interactive Brokers Group were worth $1,793,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Gamble Jones Investment Counsel increased its stake in shares of Interactive Brokers Group, Inc. (NASDAQ:IBKR) by 1.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,263 shares of the financial services provider’s stock after purchasing an additional 918 shares during the period. Gamble Jones Investment Counsel’s holdings in Interactive Brokers Group were worth $4,139,000 as of its most recent SEC filing.

  • [By Jon C. Ogg]

    Interactive Brokers Group Inc. (NASDAQ: IBKR) has a market cap of almost $26 billion, and its shares were trading basically flat at $62.00, after having been down about 1% in earlier trading indications. The consensus analyst target is $70.50, and the 52-week range is $39.70 to $80.32.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Interactive Brokers Group (IBKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Compass Point started coverage on shares of Interactive Brokers Group (NASDAQ:IBKR) in a research note published on Tuesday. The brokerage issued a neutral rating and a $74.00 price target on the financial services provider’s stock.

Top 10 Medical Stocks To Own For 2019: Nuveen Preferred Income Opportunites Fund(JPC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Hollencrest Capital Management decreased its stake in Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) by 30.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,587 shares of the financial services provider’s stock after selling 9,649 shares during the period. Hollencrest Capital Management’s holdings in Nuveen Preferred & Income Oprtnts Fnd were worth $200,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) announced a monthly dividend on Wednesday, August 1st, NASDAQ reports. Shareholders of record on Wednesday, August 15th will be given a dividend of 0.061 per share by the financial services provider on Tuesday, September 4th. This represents a $0.73 annualized dividend and a yield of 7.75%. The ex-dividend date is Tuesday, August 14th.

  • [By Ethan Ryder]

    News headlines about Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) have trended positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Nuveen Preferred & Income Oprtnts Fnd earned a media sentiment score of 0.42 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 48.1302177844966 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Top 10 Medical Stocks To Own For 2019: (RUP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Rupee (CURRENCY:RUP) traded down 0.9% against the U.S. dollar during the one day period ending at 14:00 PM ET on October 12th. Rupee has a total market capitalization of $802,724.00 and $4.00 worth of Rupee was traded on exchanges in the last day. During the last seven days, Rupee has traded 0% lower against the U.S. dollar. One Rupee coin can now be purchased for approximately $0.0323 or 0.00000515 BTC on exchanges including CoinExchange and CryptoBridge.

  • [By Max Byerly]

    Rupee (CURRENCY:RUP) traded 10.1% higher against the US dollar during the 24 hour period ending at 16:00 PM ET on September 23rd. Over the last week, Rupee has traded 73.1% higher against the US dollar. One Rupee coin can now be bought for $0.0169 or 0.00000252 BTC on major exchanges including CoinExchange and CryptoBridge. Rupee has a total market capitalization of $415,606.00 and approximately $267.00 worth of Rupee was traded on exchanges in the last day.

  • [By Shane Hupp]

    Rupert Resources Ltd (CVE:RUP) insider Alan Douglas Brimacombe purchased 25,000 shares of Rupert Resources stock in a transaction that occurred on Wednesday, May 30th. The stock was bought at an average cost of C$1.03 per share, for a total transaction of C$25,750.00.

  • [By Stephan Byrd]

    Rupert Resources Ltd (CVE:RUP) insider Alan Douglas Brimacombe sold 30,000 shares of the business’s stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of C$0.95, for a total value of C$28,500.00.

Top 10 Medical Stocks To Own For 2019: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Teachers Advisors LLC increased its position in shares of Immunomedics (NASDAQ:IMMU) by 14.9% in the 4th quarter, HoldingsChannel reports. The firm owned 211,706 shares of the biopharmaceutical company’s stock after purchasing an additional 27,385 shares during the period. Teachers Advisors LLC’s holdings in Immunomedics were worth $3,421,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Celldex Therapeutics (NASDAQ: CLDX) and Immunomedics (NASDAQ:IMMU) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings.

  • [By Logan Wallace]

    Rock Springs Capital Management LP bought a new position in Immunomedics, Inc. (NASDAQ:IMMU) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 450,000 shares of the biopharmaceutical company’s stock, valued at approximately $6,575,000. Rock Springs Capital Management LP owned 0.27% of Immunomedics at the end of the most recent reporting period.

  • [By Logan Wallace]

    Immunomedics, Inc. (NASDAQ:IMMU) Director Venbio Select Advisor Llc bought 575,000 shares of the company’s stock in a transaction on Friday, June 15th. The stock was bought at an average cost of $24.00 per share, for a total transaction of $13,800,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Immunomedics (IMMU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    After unveiling positive results for its lead drug, sacituzumab govitecan, in breast cancer at the influential American Society of Clinical Oncology (ASCO) conference, shares in Immunomedics (NASDAQ:IMMU) rallied by as much as 14.7% today before settling in for a gain of 9.3% at 3 p.m. EDT.

Top 5 Stocks To Watch For 2019

Fistula is a condition which causes urinary incontinence after blood supply to vaginal and bladder or rectal tissues is cut during prolonged obstructed labour. (Photo credit: ISSOUF SANOGO/AFP/Getty Images)

For over 35 years, I have worked tirelessly to connect the generations through earning, saving, spending, and, most importantly, sharing.  Speaking of sharing, I recently received a wake-up call when I was introduced to a medical condition that affects over 2 million women across the developing world. As such, I feel compelled to share my newfound knowledge on obstetric fistula, a terrible plight that not only causes women to lose their newborn child during a prolonged labor, but spawns continued symptoms for the rest of their lives. My goal is for us to practice true sharing through charity this Mother’s Day because there is a solution and a cure for this problem.

Top 5 Stocks To Watch For 2019: Lakeland Financial Corporation(LKFN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Vaughan Nelson Investment Management L.P. lifted its position in shares of Lakeland Financial Co. (NASDAQ:LKFN) by 3.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 878,934 shares of the financial services provider’s stock after purchasing an additional 30,687 shares during the quarter. Vaughan Nelson Investment Management L.P. owned approximately 3.48% of Lakeland Financial worth $40,634,000 as of its most recent filing with the Securities and Exchange Commission.

Top 5 Stocks To Watch For 2019: AmeriGas Partners, L.P.(APU)

Advisors’ Opinion:

  • [By John Bromels]

    If you’re like me, you probably use branded propane tanks fromAmeriGas Partners(NYSE:APU) orBlue Rhino, which is owned byFerrellgas Partners, L.P.(NYSE:FGP)(Full disclosure: Propane is propane. I use AmeriGas because it’s what the local convenience store sells.) Either one will get your burgers cooked, but which one will keep your portfolio cooking along?

  • [By Maxx Chatsko]

    Investors seeking income from energy stocks will find it difficult to match the impressive yields of Ferrellgas Partners LP (NYSE:FGP) and AmeriGas Partners (NYSE:APU), which sit at 11.9% and 9%, respectively. However, this is a textbook case of higher yields representing higher levels of risk.

Top 5 Stocks To Watch For 2019: Capella Education Company(CPLA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Capella Education (CPLA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Shares of Capella Education (NASDAQ:CPLA) reached a new 52-week high on Monday . The stock traded as high as $104.10 and last traded at $103.20, with a volume of 487 shares trading hands. The stock had previously closed at $103.70.

Top 5 Stocks To Watch For 2019: Synnex Corporation(SNX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Cross Research lowered shares of SYNNEX (NYSE:SNX) from a buy rating to a hold rating in a report released on Friday morning.

    Other research analysts have also recently issued research reports about the stock. Stifel Nicolaus reduced their price target on shares of SYNNEX from $140.00 to $130.00 and set a buy rating for the company in a report on Friday. Pivotal Research reduced their price target on shares of SYNNEX from $135.00 to $130.00 and set a buy rating for the company in a report on Friday. Needham & Company LLC reiterated a buy rating and issued a $135.00 price target (down previously from $151.00) on shares of SYNNEX in a report on Monday, April 2nd. They noted that the move was a valuation call. Zacks Investment Research upgraded shares of SYNNEX from a sell rating to a hold rating in a report on Tuesday, June 5th. Finally, ValuEngine cut shares of SYNNEX from a hold rating to a sell rating in a report on Wednesday, May 2nd. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. The stock has a consensus rating of Hold and a consensus target price of $141.14.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on SYNNEX (SNX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    We have you covered. This week, we did our digging into the numbers, and we have found three stocks that could surge 80% or more in the months ahead. Let’s dig into them as the market opens… right here.

    The Top Stock Market Stories for Thursday
    A leaked report from a Chinese government think tank warned of “financial panic” across the country. In addition to concerns about the ongoing trade battle with the United States, the National Institution for Finance & Development warned about the ongoing use of leverage in the stock market. The think tank argued that China’s central bank must be ready to step in and support the nation’s markets (the Shanghai Composite is off 20% since January) in the event of a liquidity crisis. This morning, the U.S. Department of Commerce said that Q1 gross domestic product (GDP) growth slowed far more than analysts had expected. During January through March, we saw the weakest levels of consumer spending in roughly five years. GDP clocked in at just 2.0%, a downturn from the 2.2% reported by the agency last month. Markets appear to believe that the economy has rebounded during the second quarter thanks in part to the massive tax cuts in January. However, ongoing trade tensions and increasing uncertainty around the globe could potentially spur a panic at any time. In 2018, major telecom carriers will begin rolling out 5G networks across the country, and the development could be one of the biggest ever. This technological leap is creating some incredible profit opportunities fortech stocks. According to Swedish network equipment manufacturer Ericsson ADR (Nasdaq:ERIC), new 5G-related features could produce as much as $1.3 trillion annually in additional revenue for carriers by 2026. Just imagine how much money you could make if you get in early and invest right now in the top 5G stocks. It would be a fortune. Today, we show you the undervalued stock that is going to lead this revolution, and it could make you rich.
    M

Top 5 Stocks To Watch For 2019: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Max Byerly]

    Compass Point started coverage on shares of Interactive Brokers Group (NASDAQ:IBKR) in a research note published on Tuesday. The brokerage issued a neutral rating and a $74.00 price target on the financial services provider’s stock.

  • [By Joseph Griffin]

    UBS Group AG grew its position in Interactive Brokers Group, Inc. (NASDAQ:IBKR) by 20.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,665 shares of the financial services provider’s stock after purchasing an additional 4,558 shares during the quarter. UBS Group AG’s holdings in Interactive Brokers Group were worth $1,793,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Interactive Brokers Group (IBKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Own Right Now

LISTEN TO ARTICLE 3:18 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

BOE Technology Group Co.’s stock market reversal is dramatic even by China’s outsized standards. It took less than a year for the Apple Inc. supplier to go from one of the nation’s best-performing stocks to among its worst — a precipitous selloff that may not be over.

China’s largest maker of screens for TVs and phones shed more than 32 percent of its value this year, the steepest decline among the 50 biggest companies listed in Shanghai and Shenzhen. That was prompted by ballooning supply and plunging prices for the large screens that comprise most of its business. Even earning a coveted spot on Apple’s list of top 200 suppliers couldn’t overcome fears that demand-supply imbalances will persist, analysts say.

Top 10 Performing Stocks To Own Right Now: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Interactive Brokers Group (NASDAQ:IBKR) had its price target cut by SunTrust Banks to $71.00 in a research report sent to investors on Wednesday. They currently have a $65.34 rating on the financial services provider’s stock. SunTrust Banks also issued estimates for Interactive Brokers Group’s Q3 2018 earnings at $0.54 EPS, Q4 2018 earnings at $0.59 EPS, FY2018 earnings at $2.34 EPS, Q1 2019 earnings at $0.60 EPS, Q2 2019 earnings at $0.64 EPS, Q3 2019 earnings at $0.66 EPS, Q4 2019 earnings at $0.70 EPS and FY2019 earnings at $2.60 EPS.

  • [By Stephan Byrd]

    Interactive Brokers Group (NASDAQ: IBKR) and Charles Schwab Co. Common Stock (NYSE:SCHW) are both large-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk.

  • [By Joseph Griffin]

    Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

    Get Interactive Brokers Group alerts:

    What Could Attract Investors to Interactive Brokers (finance.yahoo.com) Reviewing Charles Schwab (SCHW) and Interactive Brokers Group (IBKR) (americanbankingnews.com) Interactive Brokers Group (IBKR) Presents At Sandler O’Neill’s Global Exchange And Brokerage Conference – Slideshow (seekingalpha.com) Should You Invest In The Financial Stock Interactive Brokers Group Inc (NASDAQ:IBKR)? (finance.yahoo.com) Interactive Brokers Welcomes New Bond Disclosure Rules (finance.yahoo.com)

    Shares of Interactive Brokers Group traded up $1.20, reaching $71.38, during midday trading on Friday, according to MarketBeat Ratings. 1,131,168 shares of the company were exchanged, compared to its average volume of 859,815. The stock has a market cap of $29.39 billion, a PE ratio of 46.65, a PEG ratio of 1.65 and a beta of 0.95. Interactive Brokers Group has a one year low of $36.23 and a one year high of $80.32.

  • [By Dustin Blitchok]

    The European Union’s General Data Protection Regulation takes effect May 25, and Steve Sanders, the executive vice president of marketing and product development at Interactive Brokers (NASDAQ: IBKR), described it as the “bane of my existence.” Compliance with the regulations is taking resources from other products at the online brokerage, he said.

  • [By Max Byerly]

    Compass Point started coverage on shares of Interactive Brokers Group (NASDAQ:IBKR) in a research note published on Tuesday. The brokerage issued a neutral rating and a $74.00 price target on the financial services provider’s stock.

Top 10 Performing Stocks To Own Right Now: Park-Ohio Holdings Corp.(PKOH)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Park-Ohio (PKOH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Park-Ohio (PKOH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Park-Ohio (NASDAQ: PKOH) and Materion (NYSE:MTRN) are both small-cap industrial products companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, dividends, risk, analyst recommendations, earnings and valuation.

  • [By Logan Wallace]

    Park-Ohio (NASDAQ: PKOH) and Shiloh Industries (NASDAQ:SHLO) are both small-cap industrial products companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Top 10 Performing Stocks To Own Right Now: Monotype Imaging Holdings Inc.(TYPE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Monotype Imaging alerts:

    Should You Be Holding Monotype Imaging Holdings Inc (NASDAQ:TYPE)? (finance.yahoo.com) Monotype Imaging Holdings Inc. (TYPE) Forecasted to Earn Q1 2019 Earnings of $0.07 Per Share (americanbankingnews.com) Monotype Partners with PKU Founder Information Industry Group to Bring Latin Typefaces to Enterprise Brands and Creative Professionals in China (finance.yahoo.com) $59.42 Million in Sales Expected for Monotype Imaging Holdings Inc. (TYPE) This Quarter (americanbankingnews.com) Introducing the Walbaum Typeface: the Restoration of a Warm and Stylish Serif Design That Has Nearly Limitless Applications (finance.yahoo.com)

    TYPE has been the topic of a number of research analyst reports. B. Riley raised shares of Monotype Imaging from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $24.50 to $31.00 in a research report on Tuesday, February 20th. Zacks Investment Research raised shares of Monotype Imaging from a “hold” rating to a “buy” rating and set a $27.00 price objective on the stock in a research report on Tuesday, February 27th. ValuEngine raised shares of Monotype Imaging from a “sell” rating to a “hold” rating in a research report on Tuesday, February 20th. TheStreet downgraded shares of Monotype Imaging from a “b” rating to a “c+” rating in a research report on Friday, April 27th. Finally, BidaskClub downgraded shares of Monotype Imaging from a “hold” rating to a “sell” rating in a research report on Saturday, May 12th. Two analysts have rated the stock with a sell rating, one has given a hold rating and two have issued a buy rating to the stock. Monotype Imaging presently has an average rating of “Hold” and an average p

  • [By Joseph Griffin]

    Monotype Imaging (NASDAQ:TYPE) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

  • [By Max Byerly]

    Zscaler (NASDAQ: ZS) and Monotype Imaging (NASDAQ:TYPE) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Monotype Imaging (NASDAQ:TYPE) from a sell rating to a hold rating in a research report report published on Tuesday morning.

Top 10 Performing Stocks To Own Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Keith Speights]

    But at least three of the biotechs singled out by the FDA deserve to be on another list — investors’ buy lists. Here’s why Celgene (NASDAQ:CELG), Gilead Sciences (NASDAQ:GILD), and Jazz Pharmaceuticals (NASDAQ:JAZZ) look like great stock picks right now.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Private Capital Advisors Inc. acquired a new position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) during the second quarter, HoldingsChannel reports. The institutional investor acquired 24,200 shares of the specialty pharmaceutical company’s stock, valued at approximately $4,170,000.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Here are some of the news headlines that may have impacted Accern’s rankings:

    Get Jazz Pharmaceuticals alerts:

    Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sle… (advfn.com) Jazz Pharmaceuticals (JAZZ) Given a $194.00 Price Target at Royal Bank of Canada (americanbankingnews.com) Analyzing Jazz Pharmaceuticals (JAZZ) & Celyad (CYAD) (americanbankingnews.com) Global Marine Pharmaceuticals Market Growing at a CAGR of 7.28% to 2022 (empowerednews.net) Physicians Unaware of Neurologic Effects Related to Obstructive Sleep Apnea, Finds Jazz Pharmaceuticals Survey (sleepreviewmag.com)

    Shares of Jazz Pharmaceuticals traded up $1.75, hitting $170.75, during trading on Friday, MarketBeat reports. 928,650 shares of the company were exchanged, compared to its average volume of 466,308. The firm has a market capitalization of $10.11 billion, a price-to-earnings ratio of 17.86, a price-to-earnings-growth ratio of 0.87 and a beta of 0.97. Jazz Pharmaceuticals has a fifty-two week low of $128.58 and a fifty-two week high of $171.76. The company has a quick ratio of 2.88, a current ratio of 3.00 and a debt-to-equity ratio of 0.55.

Top 10 Performing Stocks To Own Right Now: Videocon d2h Limited(VDTH)

Advisors’ Opinion:

  • [By Logan Wallace]

    Videocon d2h (NASDAQ: VDTH) and MSG Networks (NYSE:MSGN) are both small-cap consumer discretionary companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership.

  • [By Joseph Griffin]

    Videocon d2h (NASDAQ: VDTH) and DISCOVERY COMMUNICATIONS INC. Common Stock (NASDAQ:DISCA) are both consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

Top 10 Performing Stocks To Own Right Now: Murphy Oil Corporation(MUR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Clinton Group Inc. purchased a new stake in Murphy Oil Co. (NYSE:MUR) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 14,491 shares of the oil and gas producer’s stock, valued at approximately $489,000.

  • [By Stephan Byrd]

    Murphy Oil Co. (NYSE:MUR) has earned an average rating of “Hold” from the twelve analysts that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation, two have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $31.56.

Top 10 Performing Stocks To Own Right Now: Gold Standard Ventures Corporation(GSV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Gold Standard Ventures Corp (NYSEAMERICAN:GSV) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 6,511,796 shares, a drop of 7.7% from the April 30th total of 7,056,069 shares. Based on an average daily volume of 268,131 shares, the short-interest ratio is currently 24.3 days. Approximately 5.9% of the company’s stock are sold short.

Top 10 Performing Stocks To Own Right Now: GRAVITY Co. Ltd.(GRVY)

Advisors’ Opinion:

  • [By Cooper Creagan]

    For example, if you had taken five minutes to set up a Night Trade on Gravity Co. (Nasdaq: GRVY) in October, you could’ve tripled your money, and then some.

  • [By Max Byerly]

    ILLEGAL ACTIVITY WARNING: “Gravity (GRVY) Receives Coverage Optimism Score of 0.17” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at www.tickerreport.com/banking-finance/3382037/gravity-grvy-receives-coverage-optimism-score-of-0-17.html.

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Gravity (NASDAQ:GRVY) from a strong sell rating to a sell rating in a research note issued to investors on Tuesday morning.

Top 10 Performing Stocks To Own Right Now: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Sarepta Therapeutics (NASDAQ:SRPT)’s share price reached a new 52-week high and low on Wednesday after Leerink Swann raised their price target on the stock from $88.00 to $121.00. Leerink Swann currently has an outperform rating on the stock. Sarepta Therapeutics traded as low as $95.67 and last traded at $94.81, with a volume of 42782 shares trading hands. The stock had previously closed at $92.22.

  • [By Stephan Byrd]

    Trexquant Investment LP acquired a new position in Sarepta Therapeutics (NASDAQ:SRPT) in the first quarter, Holdings Channel reports. The institutional investor acquired 7,135 shares of the biotechnology company’s stock, valued at approximately $529,000.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Sarepta Therapeutics (SRPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights]

    Three biotech stocks — Solid Biosciences (NASDAQ:SLDB), Sarepta Therapeutics (NASDAQ:SRPT), and Heron Therapeutics (NASDAQ:HRTX) — soared this week by 30% or more thanks to news that brought smiles to investors’ faces. Here’s what drove these stocks higher and whether or not they’resmart picks to buy now.

  • [By Chris Lange]

    Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares skyrocketed on Tuesday after the firm presented positive preliminary results from its midstage Duchenne muscular dystrophy (DMD) trial. Specifically, the results came from Sareptas Phase 1/2a gene therapy clinical trial assessing AAVrh74.MHCK7.micro-Dystrophin in individuals with DMD.

  • [By Logan Wallace]

    Barclays upgraded shares of Sarepta Therapeutics (NASDAQ:SRPT) from an equal weight rating to an overweight rating in a research report released on Friday morning, MarketBeat.com reports. They currently have $107.00 target price on the biotechnology company’s stock, up from their prior target price of $55.00.

Top 10 Performing Stocks To Own Right Now: Saul Centers, Inc.(BFS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Teachers Insurance & Annuity Association of America purchased a new position in shares of Saul Centers, Inc. (NYSE:BFS) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 13,437 shares of the real estate investment trust’s stock, valued at approximately $685,000. Teachers Insurance & Annuity Association of America owned approximately 0.06% of Saul Centers at the end of the most recent quarter.

  • [By Logan Wallace]

    Shares of Saul Centers, Inc. (NYSE:BFS) have been assigned a consensus recommendation of “Hold” from the seven analysts that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $54.50.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Saul Centers (BFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Saul Centers (BFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Undervalued Stocks To Buy For 2019

Buying beaten down biotech stocks is a strategy I focus on, especially at the end of each year because as tax loss selling fades, it is possible to see very strong gains into the New Year. For example, last December, I wrote an article about Immunogen (IMGN) titled “Why This $1 Biotech Stock Is A Strong Buy Now” and that stock went to over $8.50 per share in 2017. Almost a year ago, I wrote about Catalyst Pharmaceutical Partners (CPRX) when it was beaten-down due to a setback, in an article titled “Why This $1 Biotech Stock Is A Strong Buy For 2017” and now it trades for nearly $4 per share. These are the kinds of gains that are possible with biotech stocks. This keeps me looking for undervalued companies in this industry that (even if there are delays or setbacks) still have strong balance sheets and a promising pipeline. With this in mind, I have found a beaten-down biotech stock pick that appears to offer similar upside.

SCYNEXIS, Inc. (SCYX) is a biotechnology company that is focused on developing treatments for serious and life-threatening fungal infections. The lead pipeline candidate, “SCY-078” is an oral and intravenous drug treatment for several fungal infections. This company has an impressive management team, a strong balance sheet, and a promising pipeline thanks to positive results for its lead candidate. Based on the cash this company has on the balance sheet, and the strong results that its lead candidate has produced so far, it appears that this biotech stock is deeply undervalued. The stock has drifted lower in the past couple of weeks (presumably because of some tax-loss selling) but that won’t last much longer and we could even see a short squeeze soon. Let’s take a closer look below.

Top 10 Undervalued Stocks To Buy For 2019: Stage Stores, Inc.(SSI)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Best Buy Co., Inc. (NYSE: BBY) is projected to report quarterly earnings at $0.74 per share on revenue of $8.73 billion.
    McKesson Corporation (NYSE: MCK) is expected to report quarterly earnings at $3.56 per share on revenue of $51.25 billion.
    Medtronic plc (NYSE: MDT) is estimated to report quarterly earnings at $1.39 per share on revenue of $8.00 billion.
    Hormel Foods Corporation (NYSE: HRL) is projected to report quarterly earnings at $0.45 per share on revenue of $2.39 billion.
    Brady Corporation (NYSE: BRC) is expected to report quarterly earnings at $0.49 per share on revenue of $291.47 million.
    Sanderson Farms, Inc. (NASDAQ: SAFM) is projected to report quarterly earnings at $2.2 per share on revenue of $841.75 million.
    The Toronto-Dominion Bank (NYSE: TD) is estimated to report quarterly earnings at $1.16 per share on revenue of $6.86 billion.
    Royal Bank of Canada (NYSE: RY) is expected to report quarterly earnings at $1.61 per share on revenue of $8.05 billion.
    58.com Inc. (NYSE: WUBA) is projected to report quarterly earnings at $0.21 per share on revenue of $372.49 million.
    Luxoft Holding, Inc. (NYSE: LXFT) is estimated to report quarterly earnings at $0.59 per share on revenue of $228.53 million.
    The Toro Company (NYSE: TTC) is expected to report quarterly earnings at $1.21 per share on revenue of $916.73 million.
    StealthGas Inc. (NASDAQ: GASS) is projected to report quarterly earnings at $0.06 per share on revenue of $37.75 million.
    Stage Stores, Inc. (NYSE: SSI) is estimated to report earnings for its first quarter.
    Thermon Group Holdings, Inc. (NYSE: THR) is projected to report quarterly earnings at $0.2 per share on revenue of $96.24 million.
    Tuniu Corporation (NASDAQ: TOUR) is estimated to report quarterly loss at $0.03 per share on revenue of $76.72 million.

     

  • [By Lisa Levin] Gainers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) rose 32 percent to $2.89 in pre-market trading after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) rose 17.7 percent to $3.03 in pre-market trading after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares rose 12.7 percent to $3.55 in pre-market trading after the company announced the FDA acceptance of NDA for DSUVIA.
    Williams-Sonoma, Inc. (NYSE: WSM) shares rose 11.7 percent to $54.95 in pre-market trading. after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    Bilibili Inc. (NASDAQ: BILI) shares rose 9.3 percent to $13.59 in pre-market trading after announcing Q1 results.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 8.1 percent to $3.46 in pre-market trading after reporting strong Q1 earnings.
    Universal Corporation (NYSE: UVV) rose 8.1 percent to $52.35 in pre-market trading after reporting fiscal Q4 results.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 8.1 percent to $5.65 in pre-market trading after gaining 6.30 percent on Wednesday.
    CEL-SCI Corporation (NYSE: CVM) rose 6.1 percent to $3.30 in pre-market trading after climbing 9.51 percent on Wednesday.
    TransEnterix, Inc. (NYSE: TRXC) rose 6 percent to $3.10 in pre-market trading after reporting a loan deal for $40 million in term loans with Hercules Capital.
    Stage Stores, Inc. (NYSE: SSI) rose 5.6 percent to $3.40 in pre-market trading following Q1 results.
    Koss Corporation (NASDAQ: KOSS) shares rose 5.2 percent to $2.42 in the pre-market trading session after falling 2.54 percent on Wednesday.

     

  • [By Ethan Ryder]

    The Children’s Place (NASDAQ: PLCE) and Stage Stores (NYSE:SSI) are both retail/wholesale companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

  • [By WWW.GURUFOCUS.COM]

    For the details of AXAR CAPITAL MANAGEMENT L.P.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=AXAR+CAPITAL+MANAGEMENT+L.P.

    These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.Stonemor Partners LP (STON) – 6,650,613 shares, 68.21% of the total portfolio. Shares added by 8.91%Patterson-UTI Energy Inc (PTEN) – 730,000 shares, 21.11% of the total portfolio. Stage Stores Inc (SSI) – 1,750,000 shares, 6.3% of the total portfolio. Shares added by 75.00%Five Star Senior Living Inc (FVE) – 2,039,878 shares, 4.38% of the total portfolio. Added

Top 10 Undervalued Stocks To Buy For 2019: SmartFinancial, Inc.(SMBK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on SmartFinancial (SMBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    SmartFinancial (NASDAQ:SMBK) was downgraded by equities research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report released on Friday.

Top 10 Undervalued Stocks To Buy For 2019: Codexis, Inc.(CDXS)

Advisors’ Opinion:

  • [By Keith Noonan, Daniel Miller, and Maxx Chatsko]

    Having even a few of these companies working in your favor over the long term can be a life-changing event. To help put readers on to some high-growth stocks that still have big potential, we asked three Motley Fool investors to profile a top growth investment. Read on to see why they identified Codexis(NASDAQ:CDXS), ActivisionBlizzard (NASDAQ:ATVI), and Control4 Corporation (NASDAQ:CTRL) as top stocks for growth-seeking investors.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Codexis (CDXS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Citadel Advisors LLC bought a new position in shares of Codexis, Inc. (NASDAQ:CDXS) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 12,507 shares of the biotechnology company’s stock, valued at approximately $138,000.

  • [By Logan Wallace]

    Codexis (NASDAQ:CDXS) insider Michael D. Aldridge sold 22,000 shares of the stock in a transaction that occurred on Thursday, May 17th. The shares were sold at an average price of $13.54, for a total transaction of $297,880.00. Following the completion of the sale, the insider now directly owns 22,000 shares of the company’s stock, valued at approximately $297,880. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Jason Hall, Chuck Saletta, and Maxx Chatsko]

    And while investors shouldn’t count Elon Musk and Tesla out, it’s never wise to put all your hopes — and money — on a single company. We asked three investors who write for The Motley Fool — one of whom is a Tesla shareholder — for alternative ideas — stocks they think could put Tesla’s future returns to shame. They put together compelling arguments forClean Energy Fuels Corp.(NASDAQ:CLNE),Berkshire Hathaway Inc.(NYSE:BRK-A)(NYSE:BRK-B), andCodexis, Inc.(NASDAQ:CDXS).

  • [By Shane Hupp]

    Codexis (NASDAQ:CDXS) hit a new 52-week high and low during trading on Monday . The company traded as low as $14.45 and last traded at $13.98, with a volume of 520808 shares traded. The stock had previously closed at $13.50.

Top 10 Undervalued Stocks To Buy For 2019: Donegal Group, Inc.(DGICB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about Donegal Group (NASDAQ:DGICB) have been trending somewhat positive on Thursday, Accern reports. Accern ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Donegal Group earned a news impact score of 0.13 on Accern’s scale. Accern also assigned news stories about the insurance provider an impact score of 47.2596177658095 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top 10 Undervalued Stocks To Buy For 2019: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Interactive Brokers Group (IBKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Dustin Blitchok]

    The European Union’s General Data Protection Regulation takes effect May 25, and Steve Sanders, the executive vice president of marketing and product development at Interactive Brokers (NASDAQ: IBKR), described it as the “bane of my existence.” Compliance with the regulations is taking resources from other products at the online brokerage, he said.

  • [By Stephan Byrd]

    Interactive Brokers Group (NASDAQ: IBKR) and Charles Schwab Co. Common Stock (NYSE:SCHW) are both large-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk.

  • [By Max Byerly]

    Compass Point started coverage on shares of Interactive Brokers Group (NASDAQ:IBKR) in a research note published on Tuesday. The brokerage issued a neutral rating and a $74.00 price target on the financial services provider’s stock.

Top 10 Undervalued Stocks To Buy For 2019: Gabelli Dividend(GDV)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about Gabelli Dividend & Income (NYSE:GDV) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Gabelli Dividend & Income earned a news impact score of 0.18 on Accern’s scale. Accern also assigned headlines about the financial services provider an impact score of 48.1795768072103 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Top 10 Undervalued Stocks To Buy For 2019: ClearBridge American Energy MLP Fund Inc.(CBA )

Advisors’ Opinion:

  • [By Ethan Ryder]

    News headlines about ClearBridge American Energy MLP Fund (NYSE:CBA) have been trending somewhat positive on Tuesday, Accern Sentiment reports. The research firm identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ClearBridge American Energy MLP Fund earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media coverage about the investment management company an impact score of 47.3026009142931 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 10 Undervalued Stocks To Buy For 2019: Cullen/Frost Bankers, Inc.(CFR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    BlackRock Inc. grew its stake in shares of Cullen/Frost Bankers, Inc. (NYSE:CFR) by 2.8% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,251,719 shares of the bank’s stock after acquiring an additional 140,956 shares during the period. BlackRock Inc. owned about 8.23% of Cullen/Frost Bankers worth $557,051,000 at the end of the most recent quarter.

  • [By Anders Bylund, Jason Hall, Danny Vena, Jordan Wathen, and Brian Feroldi]

    In that spirit, we asked a few of our Motley Fool investors what they see as the best investment ideas at the start of July, 2018. They were quick to suggest Chinese e-commerce giantBaidu(NASDAQ:BIDU), coffee giant Starbucks (NASDAQ:SBUX), clean energy specialist TerraForm Power (NASDAQ:TERP), semiconductor veteran Intel, (NASDAQ:INTC), and Texan bankCullen/Frost Bankers(NYSE:CFR).

  • [By Ethan Ryder]

    News articles about Cullen/Frost Bankers (NYSE:CFR) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cullen/Frost Bankers earned a news sentiment score of 0.01 on Accern’s scale. Accern also assigned news stories about the bank an impact score of 46.1866283388257 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Undervalued Stocks To Buy For 2019: Nuveen Premium Income Municipal Fund, Inc.(NPI)

Advisors’ Opinion:

  • [By Max Byerly]

    Northland Power Inc. (TSE:NPI) shares hit a new 52-week high during mid-day trading on Friday . The company traded as high as C$24.86 and last traded at C$24.85, with a volume of 237841 shares trading hands. The stock had previously closed at C$24.23.

  • [By Shane Hupp]

    Northland Power Inc. (TSE:NPI) has been given an average recommendation of “Buy” by the seven ratings firms that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is C$27.21.

  • [By Logan Wallace]

    Northland Power (TSE:NPI) is set to release its earnings data after the market closes on Wednesday, May 9th. Analysts expect Northland Power to post earnings of C$0.45 per share for the quarter.

  • [By Ethan Ryder]

    Northland Power (TSE:NPI) last posted its quarterly earnings results on Wednesday, May 9th. The solar energy provider reported C$0.59 EPS for the quarter, beating the Zacks’ consensus estimate of C$0.46 by C$0.13. The business had revenue of C$486.37 million for the quarter, compared to analysts’ expectations of C$412.97 million. Northland Power had a return on equity of 26.18% and a net margin of 20.85%.

Top 10 Undervalued Stocks To Buy For 2019: Saia Inc.(SAIA)

Advisors’ Opinion:

  • [By Max Byerly]

    State of Tennessee Treasury Department trimmed its holdings in Saia Inc (NASDAQ:SAIA) by 9.5% during the first quarter, HoldingsChannel.com reports. The fund owned 17,868 shares of the transportation company’s stock after selling 1,877 shares during the period. State of Tennessee Treasury Department’s holdings in Saia were worth $1,343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Ethan Ryder]

    Mesirow Financial Investment Management Equity Management trimmed its position in Saia (NASDAQ:SAIA) by 45.8% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 162,955 shares of the transportation company’s stock after selling 137,962 shares during the period. Mesirow Financial Investment Management Equity Management owned about 0.63% of Saia worth $12,246,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Saia (NASDAQ: SAIA) and ArcBest (NASDAQ:ARCB) are both transportation companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk.

  • [By Joseph Griffin]

    Verition Fund Management LLC bought a new stake in Saia Inc (NASDAQ:SAIA) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 5,872 shares of the transportation company’s stock, valued at approximately $441,000.

  • [By Stephan Byrd]

    Saia (NASDAQ:SAIA) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued on Tuesday.

Top Undervalued Stocks To Watch For 2018

Hywind wind farm concept. Five turbines will be placed off the east coast of Scotland, near Peterhead. They will each be anchored with three suction anchors and linked together to send electricity to shore to power 22,000 households. Source: Statoil.

Seeking Alpha contributor Michael Fitzsimmons has summarized Statoil’s (NYSE:STO) Q2 results, which he suggests show that the company is undervalued and operating successfully with oil at $50/bbl or less. With net income of $0.44/share, Q2 dividend of $0.22/share and 8.1% debt ratio reduction, things looks sweet even in these challenging times. However, there is more good news to the Statoil story. Here I have a look at what Statoil is doing about growing a future beyond oil.

Top Undervalued Stocks To Watch For 2018: Prima BioMed Ltd(PBMD)

Advisors’ Opinion:

  • [By Monica Gerson]

    Prima Biomed (NASDAQ: PBMD) dropped 38.17% to $1.45 after the company reported top-line analysis of CVac Phase 2 trial.

    Tower Group International (NASDAQ: TWGP) plummeted 24.31% to $10.49. Tower Group announced its plans to release its Q2 results during the week of October 7, 2013. FBR Capital downgraded the stock from Outperform to Market Perform.

  • [By Monica Gerson]

    Prima Biomed (NASDAQ: PBMD) shares dipped 38.59% to touch a new 52-week low of $1.44 after the company reported top-line analysis of CVac Phase 2 trial.

Top Undervalued Stocks To Watch For 2018: Huntington Ingalls Industries, Inc.(HII)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    Shipbuilding and services specialistHuntington Ingalls (NYSE:HII) was spun off from Northup Grumman in early 2011. General Dynamics (NYSE:GD) is roughly six times larger and offers a far more diversified list of products and services that includes submarines, aircraft, and armored vehicles, among other things. Both, however, provide key products and services to the U.S. military. That’s normally a fairly consistent business driven by large and often very long contracts. With a supportive administration in the White House, it would seem like now is a good time to take a look at this pair of stocks. But which of these two military-industrial companies is a better buy? Using a Benjamin Grahamlens, the answer may not be what you want to hear.

  • [By Lou Whiteman]

    Huntington Ingalls Industries (NYSE:HII) and Lockheed Martin (NYSE:LMT)are each up about 25% over the past year, though Lockheed is significantly higher valued on both a price-to-earnings and price-to-sales basis. Let’s take a look at the prospects for both companies with an eye toward determining which is a better buy right now.

  • [By ]

    Huntington Ingalls (HII) : “I want you to take some profits.”

    GlaxoSmithKline (GSK) : “I like Glaxo. I think they’re doing a fantastic job.”

  • [By ]

    Cramer was bearish on Tower Semiconductor (TSEM) , Western Union (WU) , Huntington Ingalls (HII) and (LX) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Michael A. Robinson]

    On Feb. 16, Huntington Ingalls Industries Inc. (NYSE: HII) snagged a massive $1.43 billion contract to design and build the LPD 29, a San Antonio-class amphibious transport dock.

Top Undervalued Stocks To Watch For 2018: XOMA Corporation(XOMA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of XOMA Corporation (NASDAQ: XOMA) got a boost, shooting up 31 percent to $14.69. Wedbush upgraded XOMA from Neutral to Outperform.

    Energous Corp (NASDAQ: WATT) shares were also up, gaining 17 percent to $11.89. Energous reported a new, high-power, Near Field WattUp charging solution for electronic devices.

  • [By Spencer Israel]

    The following are some of the stocks discussed on the show for which co-host Joel Elconin offered technical levels.

    Bank of America Corp (NYSE: BAC) hit a low last week of $22.43, and has a big psychological level of $22.
    Goldman Sachs Group Inc (NYSE: GS) has two minor support levels from early December of $221.22 and $220.35. Under $220 it gets dicey, with support at $214.97 and $209.92.
    United States Steel Corporation (NYSE: X) has a key low of $31.33 from February 2. That number serves as support.
    Best Buy Co Inc (NYSE: BBY) has a triple top at $45.15. It's currently in a trading range from $43.75-$45.70.
    Shake Shack Inc (NYSE: SHAK) has been range bound over the last four days from $31.68 to $32.62. It has major support at the all-time low from March 15 at $30.36.
    Warren Lorenz, CEO of TechMeetsTrader, joined the show to discuss his "Facebook for stocks" platform, and how he learned how to trade by watching trading communities. Listen to the full interview with Lorenz here.
    Tommy Lackey, managing partner and portfolio manager at Relativity Capital Advisors, told us which stocks are on his nitrous scans and meltdown filters this morning. Those include XOMA Corporation (NASDAQ: XOMA) Whirlpool Corporation (NYSE: WHR) and Bed Bath & Beyond Inc. (NASDAQ: BBBY). Listen to the full interview with Lackey here.
    With the market in a slight selloff following Friday's healthcare fallout, the focus today will be which sectors, if any, rebound throughout the day. With steel stocks looking weak and gold minors and utilities looking strong, co-host Dennis Dick said he'll try to jump into those sectors if they stay weak after the open. Hear what other sectors Dick is watching here.
    With Snap Inc (NYSE: SNAP)'s 25-day quiet period for analysts over, the Street was treated to bullish ratings by Goldman Sachs, Citigroup, Morgan Stanley and others. It's worth noting, however, most of Monday morning

Top Undervalued Stocks To Watch For 2018: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Travis Hoium]

    The ups and downs of revenue and earnings atInteractive Brokers Group, Inc. (NASDAQ:IBKR)struck again in the first quarter of 2017. Trading and market making were down versus a year before,but the company still reported a profit and is making long-term adjustments that could make the business more profitable for investors.

Top Undervalued Stocks To Watch For 2018: Castlight Health, inc.(CSLT)

Advisors’ Opinion:

  • [By Todd Campbell]

    Castlight Health (NYSE:CSLT)share price climbed 13.2% Wednesday after an SEC filing revealed that Maverick Capital had significantly boosted its stake in the company to 10.6%.

Top Performing Stocks To Own Right Now

Corbus Pharmaceuticals (NASDAQ:CRBP) managed to become one of the top-performing biotech stocks on the market in 2016. Over the last 12 months, Corbus’ share price has soared 550%.

It was a bumpy ride for shareholders, though. Corbus stock had some big drops along the way, most recently falling around 25% before clawing its way back. How high can Corbus stock go from here?

Image source: Getty Images.

The main story for Corbus

There’s one driving factor behind Corbus’ success thus far: JBT-101 (also known as resunab). Thenovel synthetic oral endocannabinoid-mimetic drug is being evaluated in four clinical studies.

Corbus announced positive results in November from a phase 2 study of JBT-101 in treating systemic sclerosis, a chronic autoimmune rheumatic disease. Patients receiving the experimental drug achieved a medianCombined Response Index in diffuse cutaneous Systemic Sclerosis (CRISS) score of 33% at week 16 of treatment. Patients in the placebo group scored 0%.CRISS scores above 20% are considered to be meaningful improvement.

Top Performing Stocks To Own Right Now: Cal-Maine Foods, Inc.(CALM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cal-Maine Foods Inc (NASDAQ: CALM) posted in-line loss for its second quarter, but sales missed expectations.

    Cal-Maine Foods reported a Q2 loss of $0.48 per share on revenue of $253.5 million. Analysts were expecting a loss of $0.48 per share on revenue of $262.8 million.

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian said that Cal-Maine Foods Inc (NASDAQ: CALM) had unusually high options volume on Friday. Traders were buying the May 45 calls and Jon Najarian decided to follow the trade. He is planning to hold the position for 1 to 2 months.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Rite Aid Corporation (NYSE: RAD) to report quarterly earnings at $0.04 per share on revenue of $8.23 billion before the opening bell. Rite Aid shares gained 0.83 percent to $8.54 in after-hours trading.
    Micron Technology, Inc. (NASDAQ: MU) reported better-than-expected profit for its first quarter and issued a strong forecast for the current quarter. Micron shares climbed 9.91 percent to $22.62 in the after-hours trading session.
    Analysts expect Cal-Maine Foods Inc (NASDAQ: CALM) to post quarterly earnings at $0.48 per share on revenue of $262.83 million after the closing bell. Cal-Maine shares rose 0.12 percent to $42.75 in after-hours trading.
    Red Hat Inc (NYSE: RHT) reported upbeat earnings for its third quarter, but sales missed expectations. The company also announced that its CFO Frank Calderoni is stepping down. Red Hat shares tumbled 10.15 percent to $71.69 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Ben Levisohn]

    Cal-Maine Foods (CALM) has tumbled 6.3% to $35.00 after missing earnings forecasts.

    EXACT Sciences (EXAS) after its Cologard test was‘considered medically necessary every 3 years’ byAetna (AET). Aetna is unchanged at$126.77.

  • [By Tyler Crowe, Jordan Wathen, and Beth McKenna]

    So we asked three of our contributors to highlight a stock they see as a real underdog in the market today and why investors should be watching this stock. Here’s a quick look into why they picked banker Wells Fargo (NYSE:WFC), railcar manufacturer Greenbrier Companies (NYSE:GBX) , and egg wholesaler Cal-Maine Foods (NASDAQ:CALM)

Top Performing Stocks To Own Right Now: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Travis Hoium]

    The ups and downs of revenue and earnings atInteractive Brokers Group, Inc. (NASDAQ:IBKR)struck again in the first quarter of 2017. Trading and market making were down versus a year before,but the company still reported a profit and is making long-term adjustments that could make the business more profitable for investors.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than

Top Performing Stocks To Own Right Now: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Catabasis Pharmaceuticals Inc (NASDAQ: CATB) got a boost, shooting up 46 percent to $6.52. Catabasis Pharmaceuticals and Sarepta Therapeutics Inc (NASDAQ: SRPT) reported a joint research collaboration in Duchenne Muscular Dystrophy.

Top Performing Stocks To Own Right Now: CIENA Corporation(CIEN)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was a mixed day for the stock market, with the Dow Jones Industrials falling while the Nasdaq Composite posted modest gains. Parts of the market reacted differently to conflicting news items, which included both poor performance in the energy market and signs of promise for the economy more broadly. Despite the conflict among industry sectors, some stocks got hit particularly hard, and Rite Aid (NYSE:RAD), Ciena (NYSE:CIEN), and Express (NYSE:EXPR) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Lisa Levin]

    Ciena Corporation (NYSE: CIEN) posted downbeat earnings for its fourth quarter.

    Ciena posted Q4 adjusted earnings of $0.44 per share on revenue of $716.2 million. Analysts were expecting earnings of $0.46 per share on revenue of $716.5 million.

  • [By Trey Thoelcke]

    Ciena Corp. (NYSE: CIEN) will report its most recent quarterly results Thursday morning. The consensus estimates call for EPS of $0.49 and $726.84 million in revenue. Shares closed at $23.87 on Friday, in a 52-week range of $18.94 to $27.98. The consensus price target is $30.77.